These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 6301414
1. Nasopharyngeal carcinoma in Japan--clinical evaluation of EBV serology and EBV-associated nuclear antigens test. Takimoto T, Furukawa M, Morishita K, Umeda R, Hatano M. Auris Nasus Larynx; 1982; 9(3):151-63. PubMed ID: 6301414 [Abstract] [Full Text] [Related]
2. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan. Tamada A, Makimoto K, Yamabe H, Imai J, Hinuma Y, Oyagi A, Araki T. Cancer; 1984 Feb 01; 53(3):430-40. PubMed ID: 6318948 [Abstract] [Full Text] [Related]
3. Epstein-Barr virus-specific serodiagnostic tests in carcinomas of the head and neck. Ringborg U, Henle W, Henle G, Ingimarsson S, Klein G, Silfversward C, Strander H. Cancer; 1983 Oct 01; 52(7):1237-43. PubMed ID: 6309355 [Abstract] [Full Text] [Related]
5. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma. Chang KP, Hsu CL, Chang YL, Tsang NM, Chen CK, Lee TJ, Tsao KC, Huang CG, Chang YS, Yu JS, Hao SP. Oral Oncol; 2008 Aug 01; 44(8):784-92. PubMed ID: 18206420 [Abstract] [Full Text] [Related]
6. Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma. Pearson GR, Weiland LH, Neel HB, Taylor W, Earle J, Mulroney SE, Goepfert H, Lanier A, Talvot ML, Pilch B, Goodman M, Huang A, Levine PH, Hyams V, Moran E, Henle G, Henle W. Cancer; 1983 Jan 15; 51(2):260-8. PubMed ID: 6295597 [Abstract] [Full Text] [Related]
11. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma. Chan KH, Gu YL, Ng F, Ng PS, Seto WH, Sham JS, Chua D, Wei W, Chen YL, Luk W, Zong YS, Ng MH. Int J Cancer; 2003 Jul 10; 105(5):706-9. PubMed ID: 12740922 [Abstract] [Full Text] [Related]
12. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients. Cui J, Yan W, Xu S, Wang Q, Zhang W, Liu W, Ni A. PLoS One; 2018 Jul 10; 13(3):e0193171. PubMed ID: 29494658 [Abstract] [Full Text] [Related]
13. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx]. Mazeron MC. Bull Cancer Radiother; 1996 Jul 10; 83(1):3-7. PubMed ID: 8679277 [Abstract] [Full Text] [Related]
14. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Henle G, Henle W. Int J Cancer; 1976 Jan 15; 17(1):1-7. PubMed ID: 175020 [Abstract] [Full Text] [Related]
15. Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients. Hadar T, Rahima M, Kahan E, Sidi J, Rakowsky E, Sarov B, Sarov I. J Med Virol; 1986 Dec 15; 20(4):329-39. PubMed ID: 3025351 [Abstract] [Full Text] [Related]
16. Detection of Epstein-Barr virus antigens and antibodies by peroxidase-labeled specific immunoglobulins. Kurstak E, de Thé G, van den Hurk J, Charpentier G, Kurstak C, Tijssen P, Morisset R. J Med Virol; 1978 Dec 15; 2(3):189-200. PubMed ID: 212523 [Abstract] [Full Text] [Related]